Evidence map›Paper›PMID 28122543›Full record

ArticleBMC cancer2017

Lung cells support osteosarcoma cell migration and survival.

Shibing Yu, Mitchell Stephen Fourman, Adel Mahjoub, Jonathan Brendan Mandell, Jared Anthony Crasto, Nicholas Giuseppe Greco, Kurt Richard Weiss

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Sarcoma · 2022
    Article
  8. Article
  9. Identification of Biomarkers for Osteosarcoma Based on Integration Strategy.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shibing YuDepartment of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Mitchell Stephen FourmanDepartment of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Adel MahjoubSchool of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Jonathan Brendan MandellDepartment of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Jared Anthony CrastoDepartment of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Nicholas Giuseppe GrecoDepartment of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Kurt Richard WeissDepartment of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA. WeisKR@upmc.edu.
University of Pittsburgh · US

Funding

Exploring Sarcoma Metastatic PotentialK08CA177927 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISS, KURT RICHARD · 2013 to 2017
$827k
NCI NIH HHS K08 CA177927
6 · The paper itself

Abstract

backgroundOsteosarcoma (OS) is the most common primary bone tumor, with a propensity to metastasize to the lungs. Five-year survival for metastatic OS is below 30%, and has not improved for several decades despite the introduction of multi-agent chemotherapy. Understanding OS cell migration to the lungs requires an evaluation of the lung microenvironment. Here we utilized an in vitro lung cell and OS cell co-culture model to explore the interactions between OS and lung cells, hypothesizing that lung cells would promote OS cell migration and survival. The impact of a novel anti-OS chemotherapy on OS migration and survival in the lung microenvironment was also examined.

methodsThree human OS cell lines (SJSA-1, Saos-2, U-2) and two human lung cell lines (HULEC-5a, MRC-5) were cultured according to American Type Culture Collection recommendations. Human lung cell lines were cultured in growth medium for 72 h to create conditioned media. OS proliferation was evaluated in lung co-culture and conditioned media microenvironment, with a murine fibroblast cell line (NIH-3 T3) in fresh growth medium as controls. Migration and invasion were measured using a real-time cell analysis system. Real-time PCR was utilized to probe for Aldehyde Dehydrogenase (ALDH1) expression. Osteosarcoma cells were also transduced with a lentivirus encoding for GFP to permit morphologic analysis with fluorescence microscopy. The anti-OS efficacy of Disulfiram, an ALDH-inhibitor previously shown to inhibit OS cell proliferation and metastasis in vitro, was evaluated in each microenvironment.

resultsLung-cell conditioned medium promoted osteosarcoma cell migration, with a significantly higher attractive effect on all three osteosarcoma cell lines compared to basic growth medium, 10% serum containing medium, and NIH-3 T3 conditioned medium (p <0.05). Lung cell conditioned medium induced cell morphologic changes, as demonstrated with GFP-labeled cells. OS cells cultured in lung cell conditioned medium had increased alkaline phosphatase staining.

conclusionsLung endothelial HULEC-5a cells are attractants for OS cell migration, proliferation, and survival. The SJSA-1 osteosarcoma cell line demonstrated greater metastatic potential than Saos-2 and U-2 cells. ALDH appears to be involved in the interaction between lung and OS cells, and ALP may be a valuable biomarker for monitoring functional OS changes during metastasis.

Indexed as

Aldehyde Dehydrogenase 1 FamilyAlkaline PhosphataseAnimalsBiomarkers, TumorCell Line, TumorCell MovementCell ProliferationCell SurvivalCoculture TechniquesDisulfiramHumansIsoenzymesLungMiceNeoplasm MetastasisOsteosarcomaAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, humanALDH1A1 protein, mouseAlkaline PhosphataseBiomarkers, TumorDisulfiramIsoenzymesRetinal DehydrogenaseAldehyde dehydrogenaseDisulfiramLung microenvironmentMetastasisOsteosarcoma

Identifiers

PMID28122543
PMCPMC5267399
OpenAlexW2580764669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.